MAWCM
PLRX icon

Mine & Arao Wealth Creation & Management’s Pliant Therapeutics PLRX Stock Holding History

Mine & Arao Wealth Creation & Management’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2
Closed -$30 – 279
2024
Q1 		$30 Buy
+2
New +$33 ﹤0.01% 384

Other funds holding PLRX

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Mine & Arao Wealth Creation & Management's PLRX Position: Q2 2024 in Review

Mine & Arao Wealth Creation & Management sold out of Pliant Therapeutics (PLRX) in Q2 2024, closing a stake of 2 shares — an estimated $30 sold.

Mine & Arao Wealth Creation & Management first reported a position in PLRX in Q1 2024 and held it in 1 quarter. The position peaked at $30 in Q1 2024. 143 funds tracked by Wall St. Rank hold PLRX as of Q2 2024.

  • Mine & Arao Wealth Creation & Management reported no remaining Pliant Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Mine & Arao Wealth Creation & Management sold 2 Pliant Therapeutics shares in Q2 2024, an estimated $30.
  • Mine & Arao Wealth Creation & Management first reported a position in Pliant Therapeutics in Q1 2024 and held it in 1 quarter.
  • Mine & Arao Wealth Creation & Management's Pliant Therapeutics position peaked at $30 in Q1 2024.
  • 143 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2024.

Based on Mine & Arao Wealth Creation & Management's 13F filing for Q2 2024, filed 6 Aug 2024.